Identification of Simple Compounds with Microtubule-Binding Activity That Inhibit Cancer Cell Growth with High Potency

被引：65

作者：

Yang, Wan Seok ^{[1
]}

Shimada, Kenichi ^{[1
]}

Delva, Darnelle ^{[1
]}

Patel, Milesh ^{[1
]}

Ode, Egberamwen ^{[1
]}

Skouta, Rachid ^{[2
]}

Stockwell, Brent R. ^{[1
,2
,3
]}

机构：

[1] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA

[2] Columbia Univ, Dept Chem, New York, NY 10027 USA

[3] Columbia Univ, Howard Hughes Med Inst, New York, NY 10027 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2012年 / 3卷 / 01期

基金：

美国国家卫生研究院;

关键词：

Small molecules; cell-based screening; microtubule; anticancer drug leads; MULTIDRUG-RESISTANCE; TUMOR-CELLS; IN-VITRO; AGENTS; APOPTOSIS; DEATH;

D O I：

10.1021/ml200195s

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We analyzed more than 1 million small molecules with the goal of finding simple synthetic compounds that potently inhibit cancer cell growth. We identified three such compounds with unknown mechanisms of action. Subsequent studies revealed that all three of these small molecules target microtubules. These three scaffolds can serve as templates for developing new microtubule-targeted agents, overcoming the limits of existing microtubule-inhibiting drugs derived from complex natural products.

引用

页码：35 / 38

页数：4

共 50 条

[21] Interferons inhibit EGF-stimulated cell growth and reduce EGF binding in human breast cancer cells
Iacopino, F
Ferrandina, G
Scambia, G
BenedettiPanic, P
Mancuso, S
Sica, G
ANTICANCER RESEARCH, 1996, 16 (4A) : 1919 - 1924
[22] Therapeutic natural compounds Enzastaurin and Palbociclib inhibit MASTL kinase activity preventing breast cancer cell proliferation
Polisety, Aneesha
Misra, Gauri
Rajawat, Jyotika
Katiyar, Amit
Singh, Harpreet
Bhatt, Anant Narayan
MEDICAL ONCOLOGY, 2022, 39 (05)
[23] Therapeutic natural compounds Enzastaurin and Palbociclib inhibit MASTL kinase activity preventing breast cancer cell proliferation
Aneesha Polisety
Gauri Misra
Jyotika Rajawat
Amit Katiyar
Harpreet Singh
Anant Narayan Bhatt
Medical Oncology, 39
[24] Structure and Activity Analysis of Inauhzin Analogs as Novel Antitumor Compounds That Induce p53 and Inhibit Cell Growth
Zhang, Qi
Ding, Derong
Zeng, Shelya X.
Ye, Qi-Zhuang
Lu, Hua
PLOS ONE, 2012, 7 (10):
[25] Organophosphorus compounds selectively inhibit esterase activity and growth factor-induced cell growth in an in vitro blood brain barrier model.
Parran, DK
Li, W
Correll, L
Jortner, B
Ehrich, M
TOXICOLOGICAL SCIENCES, 2003, 72 : 266 - 267
[26] G-quadruplex compounds and cis-platin act synergistically to inhibit cancer cell growth in vitro and in vivo
Gunaratnam, Mekala
Green, Colin
Moreira, Joao Bruno
Moorhouse, Adam D.
Kelland, Lloyd R.
Moses, John E.
Neidle, Stephen
BIOCHEMICAL PHARMACOLOGY, 2009, 78 (02) : 115 - 122
[27] DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA
Joshi, Rakesh
Qin, Lyugao
Cao, Xuan
Zhong, Shanshan
Voss, Courtney
Min, Weiping
Li, Shawn S. C.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (02) : 645 - 656
[28] Identification of Fluorescent Compounds with Non-Specific Binding Property via High Throughput Live Cell Microscopy
Nath, Sangeeta
Spencer, Virginia A.
Han, Ju
Chang, Hang
Zhang, Kai
Fontenay, Gerald V.
Anderson, Charles
Hyman, Joel M.
Nilsen-Hamilton, Marit
Chang, Young-Tae
Parvin, Bahram
PLOS ONE, 2012, 7 (01):
[29] Peptide Vaccines and Peptidomimetics of EGFR (HER-1) Ligand Binding Domain Inhibit Cancer Cell Growth In Vitro and In Vivo
Foy, Kevin Chu
Wygle, Ruthie M.
Miller, Megan J.
Overholser, Jay P.
Bekaii-Saab, Tanios
Kaumaya, Pravin T. P.
JOURNAL OF IMMUNOLOGY, 2013, 191 (01): : 217 - 227
[30] Maintaining Glycogen Synthase Kinase-3 Activity Is Critical for mTOR Kinase Inhibitors to Inhibit Cancer Cell Growth
Koo, Junghui
Yue, Ping
Gal, Anthony A.
Khuri, Fadlo R.
Sun, Shi-Yong
CANCER RESEARCH, 2014, 74 (09) : 2555 - 2568

← 1 2 3 4 5 →